STK11 and neoplasm: To complement recent targeted efforts that identified SIKs as potent tumor-suppressive effectors among the direct substrates of LKB1 kinase activity, we leveraged reversible inactivation to identify LKB1-driven processes in an unbiased fashion35,36.